−Removed: MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
+Added: FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
with Respect to our Common Stock and Tradeable Warrants
15 unchanged sentences
Company did not repurchase any of its equity securities during the fourth quarter ended December 31, 2024.
−Removed: of Proceeds from the Sale of Registered Securities
−Removed: February 13, 2023, our Registration Statement, as amended, and originally filed on Form S-1 (File No.
−Removed: 333-267951) was declared effective
−Removed: by the SEC for our initial public offering of 1,317,647 units, including 197,647 additional common stock, tradeable warrants and/or non-tradeable
−Removed: warrants, by the underwriters pursuant to the exercise of the over-allotment option, each at an offering price of $6.48 per share, $0.01
−Removed: per tradeable warrant, and/or $0.01 per non-tradeable warrant, for aggregate gross proceeds of approximately $8.4 million.
−Removed: After deducting
−Removed: underwriting discounts and commissions and other estimated offering expenses incurred by us of approximately $1.1 million, the net proceeds
−Removed: from the offering were approximately $7.3 million.
−Removed: WallachBeth Capital LLC acted as sole book-running manager and the representative
−Removed: of the underwriters of the initial public offering.
−Removed: No offering costs were paid or are payable, directly, or indirectly, to our directors
−Removed: or officers, to persons owning 10% or more of any class of our equity securities, or to any of our affiliates.
−Removed: Our common stock and tradeable
−Removed: warrants are traded on Nasdaq under the symbols “BFRG” and “BFRGW”, respectively.
−Removed: has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus filed with the
−Removed: SEC on February 16, 2023.
−Removed: Upon receipt, the net proceeds from our IPO were held in cash, cash equivalents and short-term
−Removed: We initially used a portion of the net proceeds from the IPO, primarily on D&O Insurance,
−Removed: repayment of debt that was not converted in the IPO and accrued expenses for technology access, consultants and compensation.
−Removed: We also used and continue to use the proceeds for costs for operations.
−Removed: Pending such uses, we plan to continue investing the unused proceeds from
−Removed: the IPO in fixed, non-speculative income instruments and money market funds.
−Removed: February 5, 2024 the Company received net proceeds of approximately $4.9 million dollars from an underwritten public offering of 1,507,139
−Removed: shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase 1,507,139 shares of common stock
−Removed: at an offering price of $3.782.
−Removed: The 5 year warrants have an exercise price of $4.16.
−Removed: On February 21, 2024, the underwriters elected to
−Removed: exercise the over-allotment option for the purchase of an additional 218,382 shares of common stock, and the Company received additional
−Removed: net proceeds of approximately $750,000, pursuant to the exercise of the over-allotment.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.